OPHI

3.1302.49%
YT

Yehiel Tal

Director

Mr. Yehiel Tal was Chairman of CollPlant Biotechnologies Ltd. (formerly known as CollPlant Holdings Ltd.) until November 02, 2026 and had been its Chief Executive Officer since January 2010 until November 02, 2026 and serves as its Director since May 2022 and was its Interim Chairman from December 2025. He Co-founded Regentis Biomaterials, Ltd. in 2004 and served as its Chief Executive Officer. He has management experience in Israeli and American high-tech and biotech industries. Prior to Regentis Biomaterials, he served as Vice-President of Business Development at ProChon BioTech Ltd. He also served as Vice President of Marketing and Business Development at OrthoScan Technologies Ltd., Vice President of Marketing and Sales at Nextec Ltd. and Director of Business Development and Business Unit Manager at Kulicke and Soffa Industries, Inc. In 2021, he was elected to the Board of Directors of the International Society for Biofabrication. He served as Director of Regentis Biomaterials, Ltd. He holds a Bachelor's and a Master's degree in Mechanical Engineering from the Technion, Israel Institute of Technology.

Positions